Pharmaceutical companies by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 61 pharmaceutical companies ranked by one-year price change, at +403%, ahead of Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%). Figures as of 18 Nov 2026, 19:23 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Erasca+403%
- Median
- +26.9%
- Combined market value
- ZAR 87.57T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +403% | ZAR 82.1B | ZAR 233.83 | 2.63% down | 403% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +286% | ZAR 165.4B | ZAR 1,741.48 | 7.38% up | 286% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +241% | ZAR 112B | ZAR 1,651.49 | 0.83% down | 241% up | ||
| 4 | VeradermicsMANE · Health Care | +233% | ZAR 90.9B | ZAR 2,153.64 | 0.85% down | 233% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +169% | ZAR 68B | ZAR 496.70 | 2.21% down | 169% up | ||
| 6 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +126% | ZAR 129.2B | ZAR 1,644.32 | 0.00% | 126% up | ||
| 7 | Dianthus TherapeuticsDNTH · Health Care | +113% | ZAR 83.4B | ZAR 1,481.81 | 1.46% down | 113% up | ||
| 8 | TG TherapeuticsTGTX · Health Care | +107% | ZAR 171.7B | ZAR 1,135.79 | 4.76% up | 107% up | ||
| 9 | ViatrisVTRS · Health Care | +95.5% | ZAR 407.9B | ZAR 355.80 | 0.64% up | 96% up | ||
| 10 | Roivant SciencesROIV · Health Care | +90.3% | ZAR 482.2B | ZAR 665.44 | 0.57% down | 90% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | +88.2% | ZAR 78.9B | ZAR 720.42 | 0.88% down | 88% up | ||
| 12 | Amneal PharmaceuticalsAMRX · Health Care | +83.3% | ZAR 131.9B | ZAR 378.45 | 3.65% up | 83% up | ||
| 13 | Royalty PharmaRPRX · Health Care | +77.7% | ZAR 689.9B | ZAR 1,199.83 | 1.05% up | 78% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | +74.4% | ZAR 851.3B | ZAR 729.58 | 0.99% down | 74% up | ||
| 15 | GenmabGMAB · Health Care | +70.0% | ZAR 547.3B | ZAR 887.68 | 1.18% down | 70% up | ||
| 16 | Praxis Precision MedicinesPRAX · Health Care | +61.1% | ZAR 148.6B | ZAR 5,316.76 | 0.81% up | 61% up | ||
| 17 | AlkermesALKS · Health Care | +58.4% | ZAR 135.2B | ZAR 804.27 | 2.35% up | 58% up | ||
| 18 | Takeda PharmaceuticalTAK · Health Care | +53.6% | ZAR 1.18T | ZAR 368.59 | 1.48% down | 54% up | ||
| 19 | Merck & CoMRK · Health Care | +50.8% | ZAR 5.86T | ZAR 2,377.18 | 4.09% down | 51% up | ||
| 20 | Protagonist TherapeuticsPTGX · Health Care | +46.4% | ZAR 141.8B | ZAR 2,172.66 | 0.80% up | 46% up | ||
| 21 | Travere TherapeuticsTVTX · Health Care | +44.2% | ZAR 84.1B | ZAR 876.10 | 0.83% down | 44% up | ||
| 22 | Ligand PharmaceuticalsLGND · Health Care | +42.6% | ZAR 103.7B | ZAR 5,181.74 | 2.01% up | 43% up | ||
| 23 | Johnson & JohnsonJNJ · Health Care | +37.6% | ZAR 11.4T | ZAR 4,733.96 | 1.75% down | 38% up | ||
| 24 | Jazz PharmaceuticalsJAZZ · Health Care | +36.7% | ZAR 273.3B | ZAR 4,257.66 | 2.31% up | 37% up | ||
| 25 | Regeneron PharmaceuticalsREGN · Health Care | +36.3% | ZAR 1.69T | ZAR 16,340.31 | 1.32% down | 36% up | ||
| 26 | Eli LillyLLY · Health Care | +34.9% | ZAR 21.34T | ZAR 23,954.55 | 2.12% down | 35% up | ||
| 27 | Bristol-Myers SquibbBMY · Health Care | +34.0% | ZAR 2.11T | ZAR 1,032.30 | 2.67% down | 34% up | ||
| 28 | Belite BioBLTE · Health Care | +31.0% | ZAR 110B | ZAR 2,709.21 | 0.64% down | 31% up | ||
| 29 | Mirum PharmaceuticalsMIRM · Health Care | +30.5% | ZAR 104.3B | ZAR 1,597.12 | 0.47% up | 31% up | ||
| 30 | Ascendis PharmaASND · Health Care | +27.8% | ZAR 306.6B | ZAR 4,673.54 | 0.32% down | 28% up | ||
| 31 | Vertex PharmaceuticalsVRTX · Health Care | +26.9% | ZAR 2.36T | ZAR 9,300.05 | 0.70% up | 27% up | ||
| 32 | AbbVieABBV · Health Care | +25.7% | ZAR 8.74T | ZAR 4,942.81 | 2.36% down | 26% up | ||
| 33 | NovartisNVS · Health Care | +25.0% | ZAR 5.07T | ZAR 2,684.92 | 2.41% down | 25% up | ||
| 34 | United TherapeuticsUTHR · Health Care | +22.6% | ZAR 426.5B | ZAR 10,013.29 | 0.84% down | 23% up | ||
| 35 | Elanco Animal HealthELAN · Health Care | +20.5% | ZAR 232B | ZAR 464.20 | 3.87% up | 20% up | ||
| 36 | BridgeBio PharmaBBIO · Health Care | +17.2% | ZAR 261.9B | ZAR 1,344.62 | 1.27% up | 17% up | ||
| 37 | BeOne MedicinesONC · Health Care | +16.8% | ZAR 798.3B | ZAR 6,988.91 | 2.18% down | 17% up | ||
| 38 | PfizerPFE · Health Care | +14.4% | ZAR 2.77T | ZAR 485.38 | 1.39% down | 14% up | ||
| 39 | Rhythm PharmaceuticalsRYTM · Health Care | +13.0% | ZAR 144.6B | ZAR 2,085.70 | 3.46% up | 13% up | ||
| 40 | BioMarin PharmaceuticalBMRN · Health Care | +11.3% | ZAR 203.8B | ZAR 1,052.01 | 4.00% up | 11% up | ||
| 41 | Arrowhead PharmaceuticalsARWR · Health Care | +10.3% | ZAR 105.5B | ZAR 746.26 | 0.41% up | 10% up | ||
| 42 | GSKGSK · Health Care | +6.26% | ZAR 1.68T | ZAR 839.79 | 1.35% down | 6% up | ||
| 43 | Dr. Reddy's LaboratoriesRDY · Health Care | +5.27% | ZAR 216.4B | ZAR 259.59 | 1.52% up | 5% up | ||
| 44 | AstraZenecaAZN · Health Care | +2.41% | ZAR 4.79T | ZAR 3,089.13 | 1.97% down | 2% up | ||
| 45 | GrifolsGRFS · Health Care | +1.41% | ZAR 99.2B | ZAR 145.83 | 2.26% down | 1% up | ||
| 46 | SanofiSNY · Health Care | -4.08% | ZAR 1.96T | ZAR 815.94 | 0.70% down | 4% down | ||
| 47 | Axsome TherapeuticsAXSM · Health Care | -7.37% | ZAR 122.2B | ZAR 2,323.41 | 1.15% down | 7% down | ||
| 48 | Corcept TherapeuticsCORT · Health Care | -7.92% | ZAR 128.3B | ZAR 1,172.34 | 3.23% down | 8% down | ||
| 49 | Novo NordiskNVO · Health Care | -16.9% | ZAR 3.01T | ZAR 682.47 | 3.01% down | 17% down | ||
| 50 | Abbott LaboratoriesABT · Health Care | -17.0% | ZAR 3.12T | ZAR 1,802.16 | 0.45% down | 17% down | ||
| 51 | PTC TherapeuticsPTCT · Health Care | -20.2% | ZAR 86.8B | ZAR 1,039.22 | 0.41% down | 20% down | ||
| 52 | CytokineticsCYTK · Health Care | -20.3% | ZAR 123.1B | ZAR 883.62 | 1.05% down | 20% down | ||
| 53 | Cogent BiosciencesCOGT · Health Care | -20.3% | ZAR 84.5B | ZAR 485.81 | 0.90% up | 20% down | ||
| 54 | Madrigal PharmaceuticalsMDGL · Health Care | -24.0% | ZAR 161.1B | ZAR 6,936.61 | 4.92% down | 24% down | ||
| 55 | ABIVAXABVX · Health Care | -27.3% | ZAR 126.6B | ZAR 1,446.02 | 1.88% up | 27% down | ||
| 56 | ZoetisZTS · Health Care | -28.7% | ZAR 599.3B | ZAR 1,475.06 | 2.20% up | 29% down | ||
| 57 | Summit TherapeuticsSMMT · Health Care | -35.6% | ZAR 146.8B | ZAR 183.52 | 0.52% down | 36% down | ||
| 58 | InsmedINSM · Health Care | -40.1% | ZAR 456.3B | ZAR 2,079.82 | 1.28% down | 40% down | ||
| 59 | Legend BiotechLEGN · Health Care | -42.5% | ZAR 54.3B | ZAR 279.90 | 0.50% up | 42% down | ||
| 60 | Ionis PharmaceuticalsIONS · Health Care | -63.6% | ZAR 79.9B | ZAR 479.67 | 2.91% up | 64% down | ||
| 61 | Alnylam PharmaceuticalsALNY · Health Care | -66.0% | ZAR 345.7B | ZAR 2,581.36 | 4.59% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 17.2886 ZAR).
Questions and answers
Which pharmaceutical companies rank first by one-year price change?
Erasca (+403%), Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%) are the top three of the 61 pharmaceutical companies ranked by one-year price change as of 18 Nov 2026, 19:23 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by one-year price change.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by one-year price change have a combined market value of ZAR 87.57T as of 18 Nov 2026, 19:23 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceutical companies by one-year price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.